GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
91 hedge funds and large institutions have $562M invested in GenMark Diagnostics, Inc in 2016 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 7 closing their positions.
200% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
48% more capital invested
Capital invested by funds: $380M → $562M (+$182M)
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
18% more funds holding
Funds holding: 77 → 91 (+14)
1.01% more ownership
Funds ownership: 101.58% → 102.59% (+1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$19.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.6M |
| 3 |
Morgan Stanley
New York
|
+$8.54M |
| 4 |
Millennium Management
New York
|
+$5.38M |
| 5 |
JP Morgan Chase
New York
|
+$3.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$9.35M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$5.65M |
| 3 |
CCM
Cadian Capital Management
New York
|
-$4.82M |
| 4 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$3.46M |
| 5 |
Jennison Associates
New York
|
-$1.67M |
GNMK Hedge Fund Activity: Q3 2016 in Review
91 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2016, worth a combined $562M — up 48% from $380M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new GNMK positions and 7 closed out — a net gain of 14 holders — while 33 added to existing stakes and 24 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $19.6M. The largest seller was Putnam Investments, cutting an estimated $9.35M.
- 91 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2016, up from 77 in Q2 2016.
- Funds reported $562M of GenMark Diagnostics, Inc stock for Q3 2016, up 48% quarter-over-quarter.
- 21 funds opened new GenMark Diagnostics, Inc positions in Q3 2016 and 7 closed out, a net change of +14 holders.
- The largest GenMark Diagnostics, Inc buyer in Q3 2016 was HighTower Advisors, an estimated $19.6M added.
- The largest GenMark Diagnostics, Inc seller in Q3 2016 was Putnam Investments, an estimated $9.35M sold.
Based on aggregated 13F filings for Q3 2016.